Oncotelic Therapeutics, Inc. Diluted Shares Outstanding (Weighted Average)
Oncotelic Therapeutics, Inc. (OTLC) reported Diluted Shares Outstanding (Weighted Average) of 467.91 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13
- Oncotelic Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 467.91M shares, a 3.34% increase year-over-year.
- Oncotelic Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 443.80M shares, a 8.93% increase year-over-year.
- Oncotelic Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-06-30 was 452.81M shares, a 12.75% increase year-over-year.
- Oncotelic Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-03-31 was 407.42M shares, a 2.01% increase year-over-year.
- Oncotelic Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 422.23M shares, a 4.41% increase from fiscal 2024.
- Oncotelic Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 404.40M shares, a 2.08% increase from fiscal 2023.
- Oncotelic Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 396.17M shares, a 13.37% decline from fiscal 2022.
- Oncotelic Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 457.30M shares, a 50.88% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 467.91M shares 10-Q · filed 2026-08-13 | 445.60M shares 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | 443.80M shares 10-Q · filed 2026-05-14 | ||||
| 2025-12-31 | 422.23M shares 10-K · filed 2026-04-15 | ||||
| 2025-06-30 | 452.81M shares 10-Q · filed 2026-08-13 | 407.86M shares 10-Q · filed 2026-08-13 | 422.51M shares derived: average of 3 quarters · filed 2026-08-13 | 418.71M shares derived: average of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | 407.42M shares 10-Q · filed 2026-05-14 | 407.36M shares derived: average of 2 quarters · filed 2026-05-14 | 407.34M shares derived: average of 3 quarters · filed 2026-05-14 | 405.90M shares derived: average of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | 407.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | 407.30M shares derived: average of 2 quarters · filed 2026-04-15 | 405.40M shares derived: average of 3 quarters · filed 2026-04-15 | 404.40M shares 10-K · filed 2026-04-15 | |
| 2024-09-30 | 407.29M shares 10-Q · filed 2024-11-19 | 404.44M shares derived: average of 2 quarters · filed 2025-08-13 | 403.43M shares 10-Q · filed 2024-11-19 | 401.80M shares derived: average of 4 quarters · filed 2025-08-13 | |
| 2024-06-30 | 401.60M shares 10-Q · filed 2025-08-13 | 401.49M shares 10-Q · filed 2025-08-13 | 399.97M shares derived: average of 3 quarters · filed 2025-08-13 | 399.43M shares derived: average of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | 399.38M shares 10-Q · filed 2025-05-15 | 399.16M shares derived: average of 2 quarters · filed 2025-05-15 | 398.70M shares derived: average of 3 quarters · filed 2025-05-15 | ||
| 2023-12-31 | 398.95M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-12 | 398.36M shares derived: average of 2 quarters · filed 2024-11-19 | 396.17M shares 10-K · filed 2024-04-12 | ||
| 2023-09-30 | 397.78M shares 10-Q · filed 2024-11-19 | 397.78M shares 10-Q · filed 2023-11-14 | 395.24M shares 10-Q · filed 2024-11-19 | ||
| 2023-03-31 | 392.36M shares 10-Q · filed 2024-05-15 | 479.67M shares derived: average of 2 quarters · filed 2024-05-15 | 448.70M shares derived: average of 3 quarters · filed 2024-05-15 | 441.21M shares derived: average of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | 566.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-12 | 476.87M shares derived: average of 2 quarters · filed 2024-04-12 | 457.50M shares derived: average of 3 quarters · filed 2024-04-12 | 457.30M shares 10-K · filed 2024-04-12 | |
| 2022-09-30 | 386.75M shares 10-Q · filed 2023-11-14 | 402.76M shares derived: average of 2 quarters · filed 2023-11-14 | 420.74M shares 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | 418.76M shares 10-Q · filed 2022-08-22 | 418.04M shares 10-Q · filed 2022-08-22 | |||
| 2021-12-31 | 374.24M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-04-20 | 372.34M shares derived: average of 2 quarters · filed 2023-04-20 | 371.41M shares derived: average of 3 quarters · filed 2023-04-20 | 303.08M shares 10-K/A · filed 2023-04-20 | |
| 2021-09-30 | 370.44M shares 10-Q · filed 2022-11-18 | 370.00M shares derived: average of 2 quarters · filed 2022-11-18 | 279.36M shares 10-Q · filed 2022-11-18 | ||
| 2021-06-30 | 369.55M shares 10-Q · filed 2022-08-22 | 232.70M shares 10-Q · filed 2022-08-22 | |||
| 2020-06-30 | 94.74M shares 10-Q · filed 2021-08-20 | 86.54M shares 10-Q · filed 2021-08-20 | |||
| 2019-06-30 | 65.38M shares 10-Q · filed 2020-08-14 | 36.11M shares 10-Q · filed 2020-08-14 |